发明名称 ANTIVIRALE THERAPIE GEGEN HEPATITIS B MIT 2',3'-DIDESOXYNUCLEOSIDEN.
摘要 A method is disclosed for the treatment of hepadnavirus infection in animals. Animals infected with duck hepatitis B virus may be treated with the 2 min ,3 min -dideoxynucleoside of adenine, guanine, hypoxanthine, 2,6-diaminopurine or various analogs of substituted purines. Several purine 2 min ,3 min -dideoxynucleosides inhibit duck hepatitis B virus in hepatocyte culture >99% at 1 mu g/ml. Potent in vivo efficacy of the 2,6-diaminopurine 2 min ,3 min -dideoxynucleoside for clearance of duck hepatitis B virus from the sera of Pekin ducks is demonstrated. The selective effect on hepadnavirus replication by the purine 2 min ,3 min -dideoxynucleosides is based on the discovery of an unexpected sensitivity of hepadnavirus to purine 2 min ,3 min -dideoxynucleoside analogs. These compounds present a new antiviral therapy of acute or persistent hepadnavirus infections.
申请公布号 DE3873207(D1) 申请公布日期 1992.09.03
申请号 DE19883873207 申请日期 1988.08.08
申请人 THE GOVERNORS OF THE UNIVERSITY OF ALBERTA, EDMONTON, ALBERTA, CA 发明人 TYRRELL, DAVID L.J., EDMONTON ALBERTA, T5R 5P6, CA;ROBINS, MORRIS J., PROVO UTAH 84604, US;SUZUKI, SATORU, HOKKAIDO 042, JP
分类号 C07D473/16;A61K;A61K31/52;A61K31/522;A61K31/70;A61P31/12;C07D473/18;C07D473/24;C07D473/30;C07D473/32;C07D473/34;C07D473/40;(IPC1-7):A61K31/70 主分类号 C07D473/16
代理机构 代理人
主权项
地址